Absci (ABSI) Preferred Dividend Payments (2020 - 2021)
Absci (ABSI) posted Preferred Dividend Payments of $242000.0 for Q3 2021, down 76.89% sequentially from $1.0 million in Q2 2021, and down 97.37% YoY from $9.2 million in Q3 2020.
Powered by 
Analysis
Absci (ABSI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Absci has reported Preferred Dividend Payments for 2 years, with the latest figure at $242000.0 in Q3 2021.
- Quarterly Preferred Dividend Payments fell 97.37% year-over-year to $242000.0 in Q3 2021, while the trailing twelve-month figure through Jun 2022 was $242000.0 (down 97.99% YoY) and the FY2021 annual result came in at $2.3 million, up 192.82% from the prior year.
- Preferred Dividend Payments fell to $242000.0 in Q3 2021 per ABSI's latest filing, from $1.0 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $9.2 million in Q3 2020 and troughed at $242000.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 242,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 995,000.00 |
| Sep 30, 2020 | 9.22 Mn |
| Jun 30, 2020 | 13.97 Mn |